CHEO Leverages Luminex Technology.
HEALTH AND BEAUTY CLOSE-UP-30 June 2008-CHEO Leverages Luminex Technology(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com The Ontario Newborn Screening Program, located at the Children's Hospital of Eastern Ontario (CHEO), recently announced that it has accomplished the Ministry of Health and Long-Term Care's mandate to screen all babies born in...

Unsafe blood transfusions rampant.
Byline: Subroto Roy PUNE: Failure to check unsafe blood transfusions in the country is proving to be life-threatening for a large number of patients of fatal anaemia, resulting from genetic diseases like thalassemia and haemophilia. According to Tripti Pensi, consultant, HIV/AIDS Unicef India country office,...

There's always hope.
THE AIM OF the exhibition "Expression of Hope" is to honor each person living with a lysosomal storage disorder (LSD) and provide creative perspectives that inspire new ideas and renewed energy in fighting genetic disease. Numerous patient organizations from around the world encouraged their members to submit images that...

TKT Strengthens Intellectual Property Position for Rare Genetic Diseases With Issuance of Patent for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA).
CAMBRIDGE, Mass., March 13 /PRNewswire/ - Transkaryotic Therapies, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 6,200,563 entitled, "Synthetic Mammalian Sulphamidase and Genetic Sequences Encoding Same." The patent is based on work performed by Dr. John Hopwood and colleagues, who...

Third Wave, UW-Madison Forge Research Collaboration For the Identification and Treatment of Genetic Diseases.
MADISON, Wis., Feb. 6 /PRNewswire/ -- Third Wave Technologies, Inc. and the University of Wisconsin-Madison announced today that they have entered into a collaboration that will encourage new research to identify and treat genetic origins of disease. The collaboration will provide UW-Madison researchers with broad...

A new sociological imperative: towards engaging with pre-implantation genetic diagnosis.
ABSTRACT Pre-implantation genetic diagnosis (PGD) is a controversial technology in which human embryos in vitro are genetically screened (via cell biopsy) prior to selection and transfer to the womb. A review of the non-sociological literature dealing with PGD reveals a preoccupation with risk. Risk in this context...

Frost & Sullivan Accolade for Agilent Technologies' Growth Strategy Leadership.
LONDON, January 16 /PRNewswire/ -- US based Agilent Technologies Inc receives the 2006 Frost & Sullivan Growth Strategy Leadership Award for using research, collaboration and innovation to become a global leader in providing core bio-analytical and electronic measurement solutions to accelerate the design, discovery and development of new products...

Addressing nature-of-science core tenets with the history of science: an example with sickle-cell anemia & malaria.
For the past two decades, there has been increasing emphasis in science education to facilitate learning of the nature of science (National Research Council, 1996; Osborne et al., 2003). The issues that fall under the domain of nature of science are wide ranging, and while there is some disagreement...

Mother knows all: next generation of prenatal tests finds clues to baby's health in mother's blood.
For 9 months, doctors can at best make educated guesses about a growing fetus' future as a healthy human. Those first fuzzy black-and-white ultrasound images can provide a mother with the peace of mind that she has a boy or girl with a beating heart, but many developmental maladies...

Medical translator; New dean wants to quickly turn discoveries into patient benefits.
Byline: Elizabeth Cooney WORCESTER- Dr. Terence R. Flotte made a big splash early in his career when he and colleagues at Johns Hopkins pioneered gene therapy in 1995, but he's not done yet. "Terry is one of the finest clinician scientists in the United States...